secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIODESIX INC (BDSX)
CIK:        0001439725
Form:       8-K
Filed at:   2022-05-25T23:59:59+00:00
Accession:  0001193125-22-159676
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biodesix stockholders elect two Class II directors and ratify KPMG as auditor
-----------------------------------------------------------------------------

- Matthew Strobeck, Ph.D. and Charles Watts, M.D. elected as Class II directors (23.1M votes for each).
- KPMG LLP ratified as independent auditor for FY2022 with 26.5M votes for, 14,941 against.
- 31,839,317 shares outstanding as of record date March 25, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439725/000119312522159676/0001193125-22-159676-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439725/000119312522159676/d323176d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-159676

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer